name: | Brexanolone |
ATC code: | N06AX29 | route: | intravenous |
n-compartments | 2 |
Brexanolone is a neuroactive steroid and a positive allosteric modulator of GABA-A receptors, used for the treatment of postpartum depression in adult women. It is currently FDA-approved for this indication and is administered as an intravenous infusion.
Pharmacokinetic parameters reported for adult women with postpartum depression following the recommended clinical intravenous dosing regimen.